Research & Development Unit

Our expertise

Supported by our scientific and technical expertise, we provide services to meet clinical needs for personalized medicine. At the crossroads between industry and research, our team shows a unique savoir-faire. 

Our solutions are based on a clever mix of: 

Molecular Biology

Cell Biology

RadioBiology

Biological samples

Translational Research

Industrial development

Our
R&D
unit

The mission of our R&D unit is to innovate, develop and create new tests in order to propose new solutions adapted to each patient. We collaborate with research laboratories, in particular the INSERM UMR 1296 academic laboratory "Radiation: defense, health, environment", directed by Dr Nicolas Foray, in Lyon, to carry out our developments.

Our R&D unit focuses on:

  • Improving processes in order to develop simpler, faster and more efficient systems while maintaining diagnostic precision
  • The creation of new solutions applied to new diseases / technological and scientific monitoring

Publications

Predicting acute severe toxicity for head and neck squamous cell carcinomas by combining dosimetry with a radiosensitivity biomarker: a pilot study

Tumori. 2022 May 16:3008916221078061. doi: 10.1177/03008916221078061. Epub ahead of print. PMID: 35578746. Deneuve S, Bastogne T, Duclos M, Mirjolet C, Bois P, Bachmann P, Nokovitch L, Roux PE, Girodet D, Poupart M, Zrounba P, Claude L, Ferella L, Iacovelli NA, Foray N, Rancati T, Pereira S.

Proof of Concept of a Binary Blood Assay for Predicting Radiosensitivity.

Cancers (Basel). 2021 May 19;13(10):2477. doi: 10.3390/cancers13102477. PMID: 34069662; PMCID: PMC8160794. Deneuve S, Mirjolet C, Bastogne T, Duclos M, Retif P, Zrounba P, Roux PE, Poupart M, Vogin G, Foray N, Pereira S.

Fast and Binary Assay for Predicting Radiosensitivity Based on the Theory of ATM Nucleo-Shuttling: Development, Validation, and Performance.

Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):353-360. Pereira S, Bodgi L, Duclos M, Canet A, Ferlazzo ML, Devic C, Granzotto A, Deneuve S, Vogin G, Foray N.

"Méthode prédictive rapide pour caractériser la radiosensibilité et/ou le risque de toxicité tissulaire d'un individu envers une irradiation"

Brevet WO2018229439A1 Neolys Diagnostics

Influence of Nucleoshuttling of the ATM Protein in the Healthy Tissues Response to Radiation Therapy: Toward a Molecular Classification of Human Radiosensitivity.

Int J Radiat Oncol Biol Phys. 2016 Mar 1;94(3):450-60. COPERNIC project investigators, Granzotto A, Benadjaoud MA, Vogin G, Devic C, Ferlazzo ML, Bodgi L, Pereira S, Sonzogni L, Forcheron F, Viau M, Etaix A, Malek K, Mengue-Bindjeme L, Escoffier C, Rouvet I, Zabot MT, Joubert A, Vincent A, Dalla Venezia N, Bourguignon M, Canat EP, d'Hombres A, Thébaud E, Orbach D, Stoppa-Lyonnet D, Radji A, Doré E, Pointreau Y, Bourgier C, Leblond P, Defachelles AS, Lervat C, Guey S, Feuvret L, Gilsoul F, Berger C, Moncharmont C, de Laroche G, Moreau-Claeys MV, Chavaudra N, Combemale P, Biston MC, Malet C, Martel-Lafay I, Laude C, Hau-Desbat NH, Ziouéche A, Tanguy R, Sunyach MP, Racadot S, Pommier P, Claude L, Baleydier F, Fleury B, de Crevoisier R, Simon JM, Verrelle P, Peiffert D, Belkacemi Y, Bourhis J, Lartigau E, Carrie C, De Vathaire F, Eschwege F, Puisieux A, Lagrange JL, Balosso J, Foray N.
See all our publications

Our scientific partners

Follow us
Contact
Laboratory form